Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
NCT06998095
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
210
Enrollment
INDUSTRY
Sponsor class
Conditions
Severe Asthma
Sponsor
AstraZeneca